Pharmacokinetic-Pharmacodynamic Modelling of Repeated Ocrelizumab Dosing in Relapsing-Remitting Multiple Sclerosis.

Serkland T T, Oma A-K F, Hallin EI, Øverås MH, Nygaard G O, Myhr K-M, Torkildsen Ø, Röblitz S, Skrede S

Clin Pharmacokinet. 2026 Aug 28. PMID: 42663866. Abstract